These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 27312550)
21. Monitoring disease activity in juvenile dermatomyositis: the role of von Willebrand factor and muscle enzymes. Guzmán J; Petty RE; Malleson PN J Rheumatol; 1994 Apr; 21(4):739-43. PubMed ID: 8035403 [TBL] [Abstract][Full Text] [Related]
22. Effect of early treatment in polymyositis and dermatomyositis. Naji P; Shahram F; Nadji A; Davatchi F Neurol India; 2010; 58(1):58-61. PubMed ID: 20228465 [TBL] [Abstract][Full Text] [Related]
23. [Clinical analysis of pneumomediastinum complicated in polymyositis and dermatomyositis]. Tong SQ; Shi XH; Su JM; Zhao Y; Zhang FC Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(9):624-7. PubMed ID: 16681909 [TBL] [Abstract][Full Text] [Related]
24. Total creatinine kinase and isoenzyme MB activity in serum and skeletal muscle of a patient with dermatomyositis. Tsung SH; Huang TY; Han D; Loh WP Clin Chem; 1980 Dec; 26(13):1912-3. PubMed ID: 7438445 [TBL] [Abstract][Full Text] [Related]
25. Measurement of platelet-derived microparticle levels using an enzyme-linked immunosorbent assay in polymyositis and dermatomyositis patients. Shirafuji T; Hamaguchi H; Higuchi M; Kanda F Muscle Nerve; 2009 May; 39(5):586-90. PubMed ID: 19347930 [TBL] [Abstract][Full Text] [Related]
26. [Risk factors associated with cardiac involvement in patients with dermatomyositis/polymyositis]. Zuo C; Wei XD; Ye YL; Liang Y; Yin G; Yang M; Xie QB Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Sep; 44(5):801-4, 809. PubMed ID: 24325116 [TBL] [Abstract][Full Text] [Related]
27. Serum muscle enzymes, muscle pathology and clinical muscle weakness: correlation in Thai patients with polymyositis/dermatomyositis. Louthrenoo W; Weerayutwattana N; Lertprasertsuke N; Sukitawut W J Med Assoc Thai; 2002 Jan; 85(1):26-32. PubMed ID: 12075717 [TBL] [Abstract][Full Text] [Related]
28. Cyclosporin A in the treatment of refractory adult polymyositis/dermatomyositis: population based experience in 6 patients and literature review. Qushmaq KA; Chalmers A; Esdaile JM J Rheumatol; 2000 Dec; 27(12):2855-9. PubMed ID: 11128676 [TBL] [Abstract][Full Text] [Related]
29. Effects of immunosuppressive treatment on interleukin-15 and interleukin-15 receptor α expression in muscle tissue of patients with polymyositis or dermatomyositis. Zong M; Loell I; Lindroos E; Nader GA; Alexanderson H; Hallengren CS; Borg K; Arnardottir S; McInnes IB; Lundberg IE Ann Rheum Dis; 2012 Jun; 71(6):1055-63. PubMed ID: 22267334 [TBL] [Abstract][Full Text] [Related]
30. [Coexistence of hypothyroidism with polymyositis or dermatomyositis]. Lukjanowicz M; Bobrowska-Snarska D; Brzosko M Ann Acad Med Stetin; 2006; 52 Suppl 2():49-55. PubMed ID: 17471837 [TBL] [Abstract][Full Text] [Related]
31. Liver dysfunction in anti-melanoma differentiation-associated gene 5 antibody-positive patients with dermatomyositis. Nagashima T; Kamata Y; Iwamoto M; Okazaki H; Fukushima N; Minota S Rheumatol Int; 2019 May; 39(5):901-909. PubMed ID: 30790016 [TBL] [Abstract][Full Text] [Related]
32. Intravenous gamma globulin as first line therapy in polymyositis and dermatomyositis: an open study in 11 adult patients. Cherin P; Piette JC; Wechsler B; Bletry O; Ziza JM; Laraki R; Godeau P; Herson S J Rheumatol; 1994 Jun; 21(6):1092-7. PubMed ID: 7932419 [TBL] [Abstract][Full Text] [Related]
33. Elevated Serum Levels of Soluble CD163 in Polymyositis and Dermatomyositis: Associated with Macrophage Infiltration in Muscle Tissue. Peng QL; Zhang YL; Shu XM; Yang HB; Zhang L; Chen F; Lu X; Wang GC J Rheumatol; 2015 Jun; 42(6):979-87. PubMed ID: 25877505 [TBL] [Abstract][Full Text] [Related]
34. Therapy of polymyositis and dermatomyositis. Marie I; Mouthon L Autoimmun Rev; 2011 Nov; 11(1):6-13. PubMed ID: 21740984 [TBL] [Abstract][Full Text] [Related]
35. [18F]FDG uptake in proximal muscles assessed by PET/CT reflects both global and local muscular inflammation and provides useful information in the management of patients with polymyositis/dermatomyositis. Tanaka S; Ikeda K; Uchiyama K; Iwamoto T; Sanayama Y; Okubo A; Nakagomi D; Takahashi K; Yokota M; Suto A; Suzuki K; Nakajima H Rheumatology (Oxford); 2013 Jul; 52(7):1271-8. PubMed ID: 23479721 [TBL] [Abstract][Full Text] [Related]
36. [Surfactant proteins-A and D as important serum markers for interstitial lung disease in patients with polymyositis or dermatomyositis]. Chen F; Shu XM; Wang DX; Xie Y; Wang GC Zhonghua Yi Xue Za Zhi; 2012 Aug; 92(31):2182-5. PubMed ID: 23158422 [TBL] [Abstract][Full Text] [Related]
37. [Polymyositis and dermatomyositis in childhood]. Rodríguez Núñez A; Fernández Bustillo JM; Rodríguez Pérez E; Novo Rodríguez I; Pérez Becerra E; Peña Guitián J; Castro Gago M An Esp Pediatr; 1988 Oct; 29(4):288-92. PubMed ID: 3069018 [TBL] [Abstract][Full Text] [Related]
38. Decreased expression of interleukin-1alpha, interleukin-1beta, and cell adhesion molecules in muscle tissue following corticosteroid treatment in patients with polymyositis and dermatomyositis. Lundberg I; Kratz AK; Alexanderson H; Patarroyo M Arthritis Rheum; 2000 Feb; 43(2):336-48. PubMed ID: 10693873 [TBL] [Abstract][Full Text] [Related]
39. Treatment of corticosteroid-resistant polymyositis with methotrexate. Sokoloff MC; Goldberg LS; Pearson CM Lancet; 1971 Jan; 1(7688):14-6. PubMed ID: 4099314 [No Abstract] [Full Text] [Related]
40. [Polymyositis: disease course and therapy with intravenously administered immunoglobulins]. Stoll T; Michel BA; Neidhart M; Wassmer P; Neidl K; Fehr K; Wagenhäuser FJ Schweiz Med Wochenschr; 1992 Sep; 122(39):1458-65. PubMed ID: 1411405 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]